Prot #RPC01-3101: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis

Project: Research project

Project Details

StatusActive
Effective start/end date5/3/165/3/21

Funding

  • Quintiles, Inc. (Prot #RPC01-3101)
  • Celgene International II Sàrl (Prot #RPC01-3101)